On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S.

SynKIR-310, however, has an added potential to prolong antitumor T-cell function and persistence. 1 In May 2024, the FDA granted clearance to an investigational new drug application for SynKIR-310, ...

A man in his 30s has been found dead inside a house in Swindon following the discovery of an 'unidentified vial of liquid'. Emergency services rushed to a house on Collett Avenue at around 4 ...

offering advanced capabilities in vial preparation, sterilization, and accurate drug dispensing. These systems replace traditional manual processes with robotic arms and sensors, ensuring ...

Robotic vial washing and filling machines are a prime example of this trend, offering advanced capabilities in vial preparation, sterilization, and accurate drug dispensing. These systems replace ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer. Researchers at Washington University School of Medicine in St. Louis, MO, have ...

The investigational drug PMD-026 is a pan-RSK inhibitor in that it blocks all four versions of the protein -- RSK1, RSK2, RSK3 and RSK4. In breast cancer, the evidence suggests that PMD-026 may ...